Long
Does a Trader really think ECYT will gain 50% in a Month
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases. one one to see how much a stock can move is to look at the ATM Straddle to get two Measured Move Targets. The ECYT ATM April 15 Straddle is priced at $6.80 implying the stock can move to either $21.80 or $9.20 by april expiration. Obviously, by the high implied volatility we can tell that their will be a drug announcement in April. One trader thinks the stock can move to $23.25 as we saw a trader buy ECYt april 22.5 calls for $.75.
Their Risk: $75 per 1 lot
Their Reward; Unlimited
Their Breakeven; $23.25
Their Risk: $75 per 1 lot
Their Reward; Unlimited
Their Breakeven; $23.25
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.